Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) is preparing to advance its clinical trial assessing the treatment of rheumatoid arthritis to the second.
Incannex Healthcare (IXHL) Receives HREC Approval for Phase 2 Clinical Trial of IHL-675A streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from Bellberry Human Research Ethics Committee (‘HREC’) for the lead site, Emeritus Research, Camberwell, Victoria, for its phase 2 clinical trial.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has garnered ethics approval to conduct a clinical trial for its proprietary drug, IHL-42X, aimed at treating.